杜邦宣布在PFAS承诺方面取得重大进展

在操作改进、研究拨款和技术获取方面取得了关键里程碑

特拉华州威尔明顿的。2020年6月11日消息——杜邦今天宣布，在履行2019年8月提出的与每氟烷基物质和多氟烷基物质(PFAS)有关的承诺方面，已经实现了几个里程碑。这些行动推进了公司实现其目标的计划2030年可持续发展目标让世界更安全、更健康、更可持续。

杜邦首席技术与可持续发展官Alexa Dembek表示:“我们很高兴在实现PFAS化学品承诺方面取得了进展，因为我们努力实现可持续发展和环境管理的核心价值观。”“随着我们继续在这些承诺和更广泛的2030年可持续发展目标上取得进展，我们期待分享进一步的最新进展。”

迄今为止，杜邦达到了以下里程碑：

• 截至2019年底，消除了我们的产品和流程中的长链PFA，包括最近综合运营的使用。
• 在我们的许多网站上消除了基于PFAS的消防泡沫的购买和存储，并在2021年底（合法允许的地方）来消除我们网站上的所有基于PFA的消防泡沫的轨道。
• 对具有历史PFAS足迹的杜邦工厂进行持续的补救。
• 在未来3年向美国国家科学基金会(NSF)提供600万美元的无限制研究资金，以资助创新型PFAS修复技术。美国国家科学基金会最近要求作为这项计划的一部分的新型PFAS研究的提案。www.nsf.gov /酒吧/ 2020 / nsf20090 / nsf20090.jsp
• 提供关于如何使用杜邦和其他制造商的树脂技术修复PFAS的开源技术指导文件。www.ljlcyg.com/pfas/remediation-technology-sharing.html
• 支持杜邦的专有产品管理软件到包括伯克利中心的绿色化学中心，超越良性，罗格斯和其他组织。为了使该软件广泛访问其他人寻求指导对其业务中的化学替代品评估的别人，我们打算在ACS 24发射化学意识工具包^th2020年6月15 - 19日，绿色化学与工程年会。
• 与ERM.，是经认证的第三方专家和领先的全球EHS和可持续发展相关服务供应商，审查我们对当前和新兴关注的物质的管理，以进一步改进我们的流程和协议。

欲了解更多有关我们行动的信息，并审查全面的PFAS承诺，请访问我们的网站www.ljlcyg.com/pfas关注我们的推特@DuPont_news。

对杜邦公司

杜邦（纽约证券交易所：DD）是一种全球创新领导者，具有基于技术的材料，配料和解决方案，可帮助改变行业和日常生活。我们的员工采用多样化的科学和专业知识，以帮助客户推进其最佳创意，并在包括电子，运输，建筑，水，健康，食品和工人安全的主要市场中提供基本创新。更多信息可以找到www.ljlcyg.com/。

关于前瞻性陈述的警告声明

本函件包含联邦证券法所指的“前瞻性陈述”，包括经修订的《1933年证券法》第27A节和经修订的《1934年证券交易法》第21E节。在这种情况下，前瞻性陈述通常涉及预期的未来业务、财务业绩和财务状况，并经常包含诸如“期望”、“预期”、“打算”、“计划”、“相信”、“寻求”、“看到”、“将”、“将”、“目标”等词，以及这些词的类似表达和变体或否定形式。

2019年4月1日，本公司通过职业奖励的所有Dow Inc.（“Dow Distribution”的所有杰出股票完成了物料科学业务分为单独和独立的公共公司。）。本公司于2019年6月1日完成了其农业业务将其农业业务分解为一家独立的独立公共公司，以Pro RATA股息的所有股票股票在Corteva，Inc。（“Corteva Distribution”（“Corteva Distribution”））。

2019年12月15日，杜邦和IFF宣布，双方已达成最终协议，将杜邦的营养与生物科学业务与IFF合并，该交易将导致IFF向杜邦股东发行股票，但仍需等待惯例交割条件，以及包括监管机构和IFF股东在内的其他批准。

前瞻性陈述涉及不同程度，不确定和受风险，不确定性和假设的事项，其中许多超出了杜邦的控制，这可能导致实际结果与任何前瞻性陈述中表达的结果不同。前瞻性陈述不保证未来结果。Some of the important factors that could cause DuPont's actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to: (i) the parties’ ability to meet expectations regarding the timing, completion and accounting and tax treatments of the proposed transaction with IFF; changes in relevant tax and other laws, (ii) failure to obtain necessary regulatory approvals, approval of IFF’s shareholders, anticipated tax treatment or any required financing or to satisfy any of the other conditions to the proposed transaction with IFF, (iii) the possibility that unforeseen liabilities, future capital expenditures, revenues, expenses, earnings, synergies, economic performance, indebtedness, financial condition, losses, future prospects, business and management strategies that could impact the value, timing or pursuit of the proposed transaction with IFF, (iv) risks and costs and pursuit and/or implementation of the separation of the N&B Business, including timing anticipated to complete the separation, any changes to the configuration of businesses included in the separation if implemented, (v) risks and costs related to the Dow Distribution and the Corteva Distribution (together, the “Distributions”) including (a) with respect to achieving all expected benefits from the Distributions; (b) the incurrence of significant costs in connection with the Distributions, including costs to service debt incurred by the Company to establish the relative credit profiles of Corteva, Dow and DuPont and increased costs related to supply, service and other arrangements that, prior to the Dow Distribution, were between entities under the common control of DuPont; (c) indemnification of certain legacy liabilities of E. I. du Pont de Nemours and Company ("Historical EID") in connection with the Corteva Distribution; and (d) potential liability arising from fraudulent conveyance and similar laws in connection with the Distributions; (vi) failure to effectively manage acquisitions, divestitures, alliances, joint ventures and other portfolio changes, including meeting conditions under the Letter Agreement entered in connection with the Corteva Distribution, related to the transfer of certain levels of assets and businesses; (vii) uncertainty as to the long-term value of DuPont common stock; (viii) potential inability or reduced access to the capital markets or increased cost of borrowings, including as a result of a credit rating downgrade (ix) risks and uncertainties related to the novel coronavirus (COVID-19) and the responses thereto (such as voluntary and in some cases, mandatory quarantines as well as shut downs and other restrictions on travel and commercial, social and other activities) on DuPont’s business, results of operations, access to sources of liquidity and financial condition which depend on highly uncertain and unpredictable future developments, including, but not limited to, the duration and spread of the COVID-19 outbreak, its severity, the actions to contain the virus or treat its impact, and how quickly and to what extent normal economic and operating conditions resume. and (x) other risks to DuPont's business, operations and results of operations including from: failure to develop and market new products and optimally manage product life cycles; ability, cost and impact on business operations, including the supply chain, of responding to changes in market acceptance, rules, regulations and policies and failure to respond to such changes; outcome of significant litigation, environmental matters and other commitments and contingencies; failure to appropriately manage process safety and product stewardship issues; global economic and capital market conditions, including the continued availability of capital and financing, as well as inflation, interest and currency exchange rates; changes in political conditions, including tariffs, trade disputes and retaliatory actions; impairment of goodwill or intangible assets; the availability of and fluctuations in the cost of energy and raw materials; business or supply disruption, including in connection with the Distributions; ability to effectively manage costs as the company’s portfolio evolves; security threats, such as acts of sabotage, terrorism or war, global health concerns and pandemics, natural disasters and weather events and patterns which could or could continue to result in a significant operational event for DuPont, adversely impact demand or production; ability to discover, develop and protect new technologies and to protect and enforce DuPont's intellectual property rights; unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities, as well as management's response to any of the aforementioned factors. These risks are and will be more fully discussed in DuPont's current, quarterly and annual reports and other filings made with the U.S. Securities and Exchange Commission, in each case, as may be amended from time to time in future filings with the SEC. While the list of factors presented here is considered representative, no such list should be considered a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DuPont’s consolidated financial condition, results of operations, credit rating or liquidity. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. DuPont assumes no obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements is included in the section titled “Risk Factors” (Part I, Item 1A) of DuPont’s 2019 Annual Report on Form 10-K, Item 8.01 of DuPont’s current report on Form 8-K filed on April 20, 2020 and as updated by DuPont’s subsequent periodic and current reports filed with the SEC.

#########

6/11/20

Dupont™，Dupont椭圆徽标以及用™，℠或®表示的所有商标和服务标志由Dupont de Nemours，Inc。的附属公司拥有。除非另有说明，否则除非另有说明。

欲了解更多信息，请联系:

丹•特纳

+ 1 (302) 299 - 7628

daniel.a.turner@dupont.com